All HIV Aids articles – Page 2
-
ResearchChemoluminescent nanoparticles detect multiple deadly viruses in one go
A detection system can test for multiple viruses in one sample
-
News
Large HIV vaccine trial to launch in South Africa
US funding agency will enlist 5400 people for HIV vaccine study in South Africa in November
-
Business
GSK’s ViiV to buy HIV drugs from BMS
Deal hands over Bristol-Myers Squibb’s entire HIV pipeline as the company looks to quit virology research
-
FeatureA new hope in HIV prevention
New microbicide products could turn the tide against Aids for women in Africa, reports Dinsa Sachan
-
BusinessNo one should be denied medication
Exclusive interview with Yusuf Hamied, chairman of Indian generic drugmaker Cipla
-
News
Scientist imprisoned over fraudulent HIV vaccine research
Former Iowa State University researcher gets four-and-a-half years in prison for faking vaccine research funded by the NIH
-
Business
GSK commits to HIV research
Firm will partner with US university and cancels plan to sell its share of ViiV Healthcare joint venture
-
Business
First HIV drug approved as prevention
Truvada tablets can reduce the risk of infection for an HIV-negative person
-
Business
GSK drug shines in HIV trial
HIV–Aids drug candidate dolutegravir outperformed Atripla tablets in Phase III
- Previous Page
- Page1
- Page2
- Next Page